Sangamo BioSciences | Capital Ordinaire





Capital Ordinaire Changement Date
Alaunos Therapeutics USD 2.21M 2.2M 2025-09
Alnylam Pharmaceuticals USD 131.79M 130.49M 2025-09
Alterity Therapeutics Limited AUD 213.97M 144.39K 2023-06
Amgen USD 539M 1000K 2025-12
Bayer EUR 982.42M 0 2025-09
BioCryst Pharmaceuticals USD 1.9M 3K 2023-09
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 192.1M 97K 2025-09
Cipla INR 807.77M 807.43M 2025-09
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 93.54M 3.99M 2025-06
CSL USD 576M 19M 2024-12
Gilead Sciences USD 1.24B 0 2025-09
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Grifols EUR 679.73M 0 2025-09
Ionis Pharmaceuticals USD 161.14M 160.98M 2025-09
J&J USD 2.41B 584K 2025-09
Karyopharm Therapeutics USD 13K 0 2024-09
Merck USD 2.49B 15.79M 2025-09
Novartis USD 1.94B 23.4M 2025-06
Omeros USD 611K 17K 2023-12
Pfizer USD 5.69B 1000K 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Sarepta Therapeutics USD 104.77M 7.06M 2025-09
Tectonic Therapeutic USD 14.86M 111.83K 2024-12
Ultragenyx Pharmaceutical USD 96.44M 88K 2025-09
Vertex Pharmaceuticals USD 254M 2.29M 2025-09


Sangamo BioSciences Capital Ordinaire - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.